TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
1.570
-0.010 (-0.63%)
At close: Sep 15, 2025, 4:00 PM EDT
1.580
+0.010 (0.64%)
After-hours: Sep 15, 2025, 4:10 PM EDT
TELA Bio Market Cap
TELA Bio has a market cap or net worth of $62.59 million as of September 15, 2025. Its market cap has decreased by -13.85% in one year.
Market Cap
62.59M
Enterprise Value
70.76M
1-Year Change
-13.85%
Ranking
Category
Stock Price
$1.57
Market Cap Chart
Since November 8, 2019, TELA Bio's market cap has decreased from $146.94M to $62.59M, a decrease of -57.40%. That is a compound annual growth rate of -13.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 62.59M | -47.38% |
| Dec 31, 2024 | 118.95M | -26.62% |
| Dec 29, 2023 | 162.12M | -26.42% |
| Dec 30, 2022 | 220.33M | 18.68% |
| Dec 31, 2021 | 185.65M | -14.47% |
| Dec 31, 2020 | 217.06M | 46.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |